| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |